# Lamivudine

NDC: 57237-274
Generic name: Lamivudine
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20161121

FDA application: ANDA077695

## Active ingredients

- LAMIVUDINE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57237-274"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57237-274
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bed2e227-8d36-40ea-bbbf-d8793bfda425